The RACGP's recent submission to clinical guidelines for cervical cancer management highlights a critical issue: the need for better care coordination, especially for patients in rural and remote areas. While the guidelines recognize GPs' integral role in multidisciplinary care, the RACGP emphasizes the challenges faced by those in remote regions, which could potentially put patients at risk.
One of the main concerns is the lack of clarity in communication between GPs and hospitals. Professor Mark Morgan, the RACGP Expert Committee's Quality Care Chair, notes that referral services may underestimate the coordination and travel required for patients in rural areas. This often results in patients having to make multiple long-distance journeys for consultations, imaging, and treatment, which could be avoided with better appointment scheduling and consolidation.
Dr. Magdalena Simonis, a GP with a special interest in women's health, echoes these concerns. She highlights the 'very long wait times' and greater access disparity faced by cervical cancer patients in rural and remote areas. The issue goes beyond just making appointments; it's about the practicalities of accessing healthcare services, including transportation and the time and resources required for travel.
The RACGP's submission also points out the absence of clarity regarding patient recalls and reminders for repeat testing following a cervical cancer diagnosis. This lack of coordination can lead to patients not receiving necessary follow-up care and GPs not being informed about the outcomes of referrals. Dr. Simonis emphasizes that care coordination is often neglected, and the current system leaves patients vulnerable.
These issues are particularly concerning given the declining HPV vaccination rates, which are essential for the elimination of cervical cancer in Australia by 2035. The Federal Government's confidence in meeting this target is undermined by the Department of Health's report of declining HPV vaccination among 15-year-olds. The 2024-25 HPV vaccination rates were 81.50% for females and 78.44% for males, down from the previous year, indicating a need for improved efforts to meet the 90% coverage target by 2030.
Dr. Simonis also highlights the issue of vaccine hesitancy, which is a significant challenge for the Australian health system. The fragmentation of care and the lack of oversight in general practice contribute to the problem, making it difficult to address vaccine hesitancy effectively.
In conclusion, the RACGP's submission highlights the urgent need for improved care coordination, especially for patients in rural and remote areas. Addressing these issues is crucial to ensuring that cervical cancer patients receive the necessary care and support, and to achieving the goal of eliminating cervical cancer in Australia.
